Botox maker Allergan eyes Shire bid
Tuesday 29 April 2014
Botox maker Allergan is considering a takeover of drugs firm Shire as the deals frenzy in the pharmaceuticals industry intensifies.
Allergan is considering making a new bid for the FTSE 100 company, according to Reuters, hot on the heels of US giant Pfizer attempting to buy rival AstraZeneca in a possible $105 billion (£62.4 million) deal and GlaxoSmithKline agreeing a multi-billion dollar asset swap with one of its rivals.
Allergan — itself fighting a $47 billion takeover bid from Valeant and activist investor Bill Ackman — is gearing up for another punt at Shire after having failed with an previous attempt in recent months.
In response, shares in Shire today gained 3.8% to 3411p, making them the top risers on the blue-chip index.A combination of Allergan and Shire would create a pharmaceutical giant with a combined market value of almost $72 billion and annual sales of more than $11 billion. Analysts believe Allergan would use Dublin-based Shire to lower its tax.
News of the potential deal comes after Pfizer yesterday took its battle to buy AstraZeneca public, saying it had been rebuffed by the firm for a second time at the weekend.
The pharmaceutical sector also saw GlaxoSmithKline sell its cancer drugs business to Novartis last week, with the Swiss firm’s vaccines unit going in the opposite direction.
Elsewhere, US generic drugs maker Mylan has had two bids rejected to buy Sweden’s Meda.
In the wider healthcare industry, recent M&A activity has included Zimmer Holdings, the US maker of medical devices, agreeing to buy rival Biomet in a deal worth $13.4 billion. Analysts have said that this could be a prelude to further consolidation in the medical equipment sector, speculating that British-based hip-joint maker Smith & Nephew could be a target for Johnson & Johnson.
- 2 Russian girl takes her own life after parents find pornography on her computer
- 4 Ball pool for adults opens in London
- 5 Amal Clooney gives excellent response to fashion question at European Court of Human Rights
Russian girl takes her own life after parents find pornography on her computer
Kim Kardashian on Bruce Jenner's 'story': 'We support him no matter what, and I think when the time is right, he'll talk'
Michelle Obama highlights harsh restrictions faced by Saudi women after meeting King Salman without wearing a headscarf
Ball pool for adults opens in London
Amal Clooney gives excellent response to fashion question at European Court of Human Rights
9 reasons Greece's experiment with the radical left is doomed to failure
'We would evict Queen from Buckingham Palace and allocate her council house,' say Greens
Greece elections: Syriza and EU on collision course after election win for left-wing party
Have we reached 'peak food'? Shortages loom as global production rates slow
British Muslim school children suffering a backlash of abuse following Paris attacks
British grandmother Lindsay Sandiford faces execution by firing squad in Indonesia
iJobs Money & Business
£13000 per annum: Recruitment Genius: This Pension Specialist was established ...
£23000 - £26000 per annum + Benefits: Ashdown Group: Market Research Executive...
£25000 - £35000 per annum: Recruitment Genius: A Technical Report Writer is re...
Competitive salary & benefits!: MBDA UK Ltd: MBDA UK LTD Indirect Procurement...